Health Canada
- Status: approved
🇨🇦 Agonist GnRH Acetate Triptoreline in Canada
Agonist GnRH Acetate Triptoreline (Agonist GnRH Acetate Triptoreline) regulatory status in Canada.
Marketing authorisation
Agonist GnRH Acetate Triptoreline in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Agonist GnRH Acetate Triptoreline approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Agonist GnRH Acetate Triptoreline in Canada?
Instituto Valenciano de Infertilidad, IVI VALENCIA is the originator. The local marketing authorisation holder may differ — check the official source linked above.